| Nicholas Peterson, CAA | |
|
36000 Euclid Ave, Willoughby, OH 44094-4625 | |
| (440) 953-9600 | |
| Not Available |
| Full Name | Nicholas Peterson |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 5 Years |
| Location | 36000 Euclid Ave, Willoughby, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386297869 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 67.000388 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Health | Concord, OH | Hospital |
| Lake Health Beachwood Medical Center | Beachwood, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement changes made in an intensive care unit (ICU) were still in practice five years later — benefiting both patients and the health care facility. Those changes included new protocols for treating critically ill patients by encouraging early physical therapy in the ICU.
Covidien, a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.
In a special section in advance of the International AIDS Conference, Science examines the "state of the HIV/AIDS epidemic in Russia and Ukraine, which account for more than 90% of HIV infections in Eastern Europe."
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
› Verified 5 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement changes made in an intensive care unit (ICU) were still in practice five years later — benefiting both patients and the health care facility. Those changes included new protocols for treating critically ill patients by encouraging early physical therapy in the ICU.
Covidien, a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.
In a special section in advance of the International AIDS Conference, Science examines the "state of the HIV/AIDS epidemic in Russia and Ukraine, which account for more than 90% of HIV infections in Eastern Europe."
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
› Verified 5 days ago
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement changes made in an intensive care unit (ICU) were still in practice five years later — benefiting both patients and the health care facility. Those changes included new protocols for treating critically ill patients by encouraging early physical therapy in the ICU.
Covidien, a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.
In a special section in advance of the International AIDS Conference, Science examines the "state of the HIV/AIDS epidemic in Russia and Ukraine, which account for more than 90% of HIV infections in Eastern Europe."
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
› Verified 5 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement changes made in an intensive care unit (ICU) were still in practice five years later — benefiting both patients and the health care facility. Those changes included new protocols for treating critically ill patients by encouraging early physical therapy in the ICU.
Covidien, a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.
In a special section in advance of the International AIDS Conference, Science examines the "state of the HIV/AIDS epidemic in Russia and Ukraine, which account for more than 90% of HIV infections in Eastern Europe."
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
› Verified 5 days ago
| Entity Name | Ohio Anesthesia Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639348113 PECOS PAC ID: 9537222138 Enrollment ID: O20090108000069 |
News Archive
In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement changes made in an intensive care unit (ICU) were still in practice five years later — benefiting both patients and the health care facility. Those changes included new protocols for treating critically ill patients by encouraging early physical therapy in the ICU.
Covidien, a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.
In a special section in advance of the International AIDS Conference, Science examines the "state of the HIV/AIDS epidemic in Russia and Ukraine, which account for more than 90% of HIV infections in Eastern Europe."
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Peterson, CAA 7757 Auburn Rd Ste 15, Concord Township, OH 44077-9604 Ph: (440) 350-0832 | Nicholas Peterson, CAA 36000 Euclid Ave, Willoughby, OH 44094-4625 Ph: (440) 953-9600 |
News Archive
In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement changes made in an intensive care unit (ICU) were still in practice five years later — benefiting both patients and the health care facility. Those changes included new protocols for treating critically ill patients by encouraging early physical therapy in the ICU.
Covidien, a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.
In a special section in advance of the International AIDS Conference, Science examines the "state of the HIV/AIDS epidemic in Russia and Ukraine, which account for more than 90% of HIV infections in Eastern Europe."
The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
› Verified 5 days ago
Todd A Lewis, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 36000 Euclid Ave, Willoughby, OH 44094 Phone: 440-350-0832 Fax: 440-354-7420 | |
Jennifer J.r. Loomis, AA-C Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 36000 Euclid Ave, Willoughby, OH 44094 Phone: 440-350-0832 Fax: 440-354-7420 | |
Jessica Lee, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 36000 Euclid Ave, Willoughby, OH 44094 Phone: 440-350-0832 Fax: 440-354-7420 | |
Anthony J Koury, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 36000 Euclid Ave, Willoughby, OH 44094 Phone: 440-953-9600 | |
Rebecca C Keating, AA-C Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 36000 Euclid Ave, Willoughby, OH 44094 Phone: 440-350-0832 Fax: 440-579-0191 | |
Ryan A Ferra, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 36000 Euclid Ave, Willoughby, OH 44094 Phone: 440-350-0832 Fax: 440-579-0191 |